Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2006
10/12/2006US20060229259 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
10/12/2006US20060229246 Peptide-enhanced transfections
10/12/2006US20060229245 Lyophilized HGF preparations
10/12/2006US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
10/12/2006US20060229235 Target-binding motif linked to a 3 beta-cholesterylamine derivative membrane-binding element by a beta-alanine subunit; for delivering a protein, peptide, drug, prodrug, lipid, nucleic acid, carbohydrate or small molecule into a target cell via receptor-mediated endocytosis
10/12/2006US20060229234 Peptide factor
10/12/2006US20060228805 Method of measuring protein solubility, process for producing crystal and apparatus therefor
10/12/2006US20060228783 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides
10/12/2006US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders
10/12/2006US20060228781 Synthetic gene coding for human granulocyte-colony stimulating factor for the expression in e.coli
10/12/2006US20060228780 Chromatographic method and system for purifying a botulinum toxin
10/12/2006US20060228779 Method for producing factor G derived from horseshoe crab
10/12/2006US20060228778 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
10/12/2006US20060228777 Animal product free media and processes for obtaining a botulinum toxin
10/12/2006US20060228775 Differential expression of nucleic acid molecules
10/12/2006US20060228773 Method for preparing recombinant heterocarpine
10/12/2006US20060228763 Periostin-based diagnostic assays
10/12/2006US20060228761 Novel RIP3 associated cell cycle proteins, compositions and methods of use
10/12/2006US20060228757 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity
10/12/2006US20060228751 Using vector to transform cells with rice Pi2-like disease resistance gene and generating pest resistant rice
10/12/2006US20060228725 Method using a nonlinear optical technique for detection of interactions involving a conformational change
10/12/2006US20060228724 Assays for screening presence of variant NTE nucleotide sequences in sample; therapeutic agents, ligands, and modulators
10/12/2006US20060228715 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
10/12/2006US20060228712 Incubating the polynucleotide array with at least one of a labeled polynucleotide derived from a coryneform bacterium, a labeled polynucleotide derived from a mutant of the coryneform bacterium or a labeled polynucleotide,detecting any hybridization, analyzing
10/12/2006US20060228710 Novel therapeutic targets in cancer
10/12/2006US20060228709 Novel fibulin-like polypeptides
10/12/2006US20060228706 Methods of diagnosing and treating diabetes and insulin resistance
10/12/2006US20060228705 Cancer-linked gene as target for chemotherapy
10/12/2006US20060228697 Generating viral replicon having an increased replication activity in a Huh7 cells using variant viral coding sequences; prevention and treatment of liver inflammation, infection and failure
10/12/2006US20060228445 biosynthesis producing vinegar; using the genes of acetobacter to encode a protein involved in shortening the growth promotion and resistance to acetic acid in the presence of a high acetic acid concentration; genetic engineering
10/12/2006US20060228407 Enhanced delivery via serpin enzyme complex receptor
10/12/2006US20060228398 Purified, heat stable, amino terminus-methylated, carboxy-terminus reduced peptide isolated from Brevibacillus comprising {4-methyl-4-[-2-butenyl]-4,N-methyl-Threonine}-leucine-ornithine-isoleucine-valine-valine-lysine-valine-lysine-tyrosine-leucine-valine alcohol; immunomodulators; infections
10/12/2006US20060228392 capable of enhancing the formation of osseous tissue in the animal in which it is implanted comprising a biocompatible matrix and a NELL-1 protein in an amount effective for stimulating a progenitor cell such that it is activated to differentiate into an osteoblast
10/12/2006US20060228378 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses
10/12/2006US20060228377 Gram-positive bacteria deprived of HtrA protease activity and their uses
10/12/2006US20060228370 7a5/Prognostin and use thereof for the diagnostic and therapy of tumors
10/12/2006US20060228365 Protein and gene involved in myocyte differentiation
10/12/2006US20060228359 antibody; host cell; hybridoma;
10/12/2006US20060228357 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
10/12/2006US20060228356 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease
10/12/2006US20060228354 Modified ADAMTS4 molecules and method of use thereof
10/12/2006US20060228353 PTH1R and PTH3R receptors, methods and uses thereof
10/12/2006US20060228335 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof
10/12/2006US20060228334 Modified adenoviral fiber with ablated to cellular receptors
10/12/2006US20060228332 Assembly and folding of Fc-interferon-beta fusion proteins
10/12/2006US20060228331 IL-21 Derivatives and variants
10/12/2006US20060228330 Dominant negative proteins and methods thereof
10/12/2006US20060228329 Homogeneous preparations of IL-31
10/12/2006US20060228327 administration of an effective amount of a CC-chemokine mutant having reduced glycosaminoglycan (GAG)-binding activity as compared to the wild type peptide to a subject with hepatitis; counteracts liver fibrotic injury
10/12/2006DE102005014687A1 Zusammensetzung enthaltend ß-Defensin 2 Composition containing ß-defensin 2
10/12/2006CA2604855A1 Ehrlichia canis diva (differentiate infected from vaccinated animals)
10/12/2006CA2604488A1 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
10/12/2006CA2603805A1 Use of rip in treating staphylococcus aureus infections
10/12/2006CA2603245A1 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
10/12/2006CA2602654A1 Method for shielding functional sites or epitopes on proteins
10/12/2006CA2602611A1 Methods of producing proteins having triple-helix structure
10/12/2006CA2601857A1 Axmi-027, axmi-036 and axmi-038, a family of delta-endotoxin genes and methods for their use
10/11/2006EP1710582A2 Suppressor genes
10/11/2006EP1710314A1 Humanized immunoglobulin reactive with alpha4beta7 integrin
10/11/2006EP1710313A1 Gene for a heat resistant enzyme of amino acid biosynthetic pathway derived from thermophilic Coryneform bacteria
10/11/2006EP1710312A1 Plant-optimized polynucleotide encoding approximately 45 kDa pesticidal protein
10/11/2006EP1710311A2 Antigenic polypeptides
10/11/2006EP1710310A1 Novel serum type streptococcus mutans and utilization of the same
10/11/2006EP1710309A2 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis
10/11/2006EP1710299A2 Secreted proteins and nucleic acids encoding them
10/11/2006EP1710254A2 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
10/11/2006EP1710253A2 Tumour markers
10/11/2006EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/11/2006EP1710251A1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide
10/11/2006EP1710250A1 Method for preparing serum albumin through heat-treatment in presence of divalent cation
10/11/2006EP1709976A1 Emt- inducing agents
10/11/2006EP1709973A1 Method of suppressing cancer
10/11/2006EP1709447A2 Method and device for detecting feline immunodeficiency virus
10/11/2006EP1709421A1 Methods for diagnosis and pronosis of cancers of epithelial origin
10/11/2006EP1709183A2 Method of modifying plant phenotypes with nonsymbiotic hemoglobin
10/11/2006EP1709179A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them
10/11/2006EP1709177A2 Dna-sequence and recombinant production of group 4 major allergens from cereals
10/11/2006EP1709170A2 Expression of mammalian proteins in pseudomonas fluorescens
10/11/2006EP1709166A1 Process for the preparation of l-amino acids with amplification of the zwf gene
10/11/2006EP1709165A2 Polypeptides of alicyclibacillus
10/11/2006EP1709162A2 A novel process of hepatitis a vaccine preparation
10/11/2006EP1709161A2 Human therapeutic cells secreting nerve growth factor
10/11/2006EP1709157A1 E.coli mutant containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same
10/11/2006EP1709084A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins
10/11/2006EP1709081A2 Fusion polypeptides capable of activating receptors
10/11/2006EP1709075A2 Treatment of viral infections
10/11/2006EP1709074A1 Cytokine binding domains
10/11/2006EP1709073A2 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
10/11/2006EP1709072A1 Variants of the extracellular domain of bcma and uses thereof
10/11/2006EP1709071A1 Glucagon-like peptide-1 analogs with long duration of action
10/11/2006EP1709070A1 Peptides for treatment of autoimmune diseases
10/11/2006EP1709069A2 Anticariogenic proteins and peptides & saccharides
10/11/2006EP1709068A2 Plant activation of insect toxin
10/11/2006EP1709067A2 Lawsonia intracellularis subunit vaccines
10/11/2006EP1709065A2 A counterion exchange process for peptides
10/11/2006EP1709064A2 Dna sequence, and recombinant production of the grass pollen allergen lol p 4
10/11/2006EP1708755A2 Transglutaminase mediated conjugation of peptides
10/11/2006EP1708753A1 Use of goat serum for veterinary treatment
10/11/2006EP1708748A2 Influenza immunogen and vaccine
10/11/2006EP1708746A2 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof